Koru Pharma Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Koru Pharma Co., Ltd. - overview
Established
2016
Location
Seoul, -, South Korea
Primary Industry
Pharmaceuticals
About
Founded in 2016 and based in Seoul, South Korea, Koru Pharma Co. , Ltd. , operates as a biopharmaceutical company that develops and manufactures aesthetic medicinal products with anti-ageing and skin-lifting properties. In Q3 2022, new investor Xinova Investment led a KRW 6 billion in pre-IPO funding for Koru Pharma Co.
, Ltd. As of 2023, the company is led by its CEO, Roman Vernidub, and has manufacturing sites in South Korea, the USA, and Europe. The company offers various pharmaceutical products that include Avalon, Crystal, Crystal Lite, Crystal Deep, Crystal Ultra, Mesoheal Body, Mesoheal Body, Mesoheal Shape, products for mesotherapy like Crystal Hydro PDRN, Mesoheal Pink Glow, Mesoheal Dual, Velancia Cog, Velvet Dual Lift, Velancia Double, DrPeel MCA Peeling Solution, DrPeel Post-Peel Care Cream, and many more. The company also provides various masks, including Crystal Carboxy CO2 Gel Mask, Mask – Collagen, Mesohemp Hemp Seed Oil Face Mask, and many more.
The company generates revenue by selling various pharmaceutical products.
Current Investors
Xinova Investment, KB Investment, DSC Investment
Primary Industry
Pharmaceuticals
Sub Industries
Aesthetic Medicine, Medical Supplies, Pharmaceutical Research & Development, Medicinal Chemicals & Botanicals
Website
www.korupharma.co.kr
Verticals
Manufacturing
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.